Amicus Therapeutics
Price & Volume
Stats
See more52W Range | $8.78-$14.02 |
Market Cap | $2.7B |
Shares Short | 17M |
Financials
See moreRevenue (12 Mos) | $528.2M |
Revenue Growth (YoY) | 30.1% |
Gross Profit (12 Mos) | $475.3M |
Diluted EPS | -$0.18 |
News
See moreYahoo Finance • 4 days ago
Amicus Therapeutics Announces Full-Year 2024 Financial Results and Corporate Updates
Yahoo Finance • 6 days ago
Kuehn Law Encourages Investors of Amicus Therapeutics, Inc. to Contact Law Firm
Yahoo Finance • 13 days ago
Amicus Therapeutics to Announce Full-Year 2024 Financial Results on February 19, 2025
Yahoo Finance • 20 days ago
Amicus Therapeutics Announces Presentations and Posters at the 21st Annual WORLDSymposium™ 2025
About
CEO | Mr. Bradley L. Campbell M.B.A. |
Address | 47 Hulfish Street, Princeton, NJ, United States, 08542 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 499 |
